People · Operator
Named in public records as an officer, director or promoter · active 2017–2023 · Biotechnology, Software / Tech, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GelSana Therapeutics, Inc. | — | Biotechnology | Seed | $3.5M | $23.7M | 2023 |
| Incident Response Technologies, Inc. | — | Software / Tech | Seed | $2.4M | $41.7M | 2017 |
| Microgrid Labs, Inc. | — | Software / Tech | Seed | $2.3M | $38.6M | 2021 |
| Aspero Medical, Inc. | — | Healthtech | Pre-Seed | $580K | $20.0M | 2019 |
Mike Freeman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mike Freeman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jim Kasic | 1 | 2 |
| Diana Verrilli | 1 | 1 |
| Melissa Krebs | 1 | 1 |
| Jon Fernandez | 1 | 1 |
| Narayanan Sankar | 1 | 1 |
| Namit Singh | 1 | 1 |
| Harold Michael | 1 | 1 |
| Jarret Winkelman | 1 | 1 |
| Mark Rentschler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.